About Y-mAbs Therapeutics, Inc. - Common Stock (YMAB)
Y-Mabs Therapeutics Inc. is a biotechnology company focused on discovering and developing innovative antibody therapeutics for the treatment of cancer, particularly in pediatric populations. The company specializes in engineered monoclonal antibodies designed to target specific tumor-associated antigens, leveraging advanced technologies to enhance therapeutic efficacy and safety. Y-Mabs is dedicated to addressing unmet medical needs by advancing its product candidates through clinical trials, with the goal of improving outcomes for patients with various forms of cancer. Read More
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.
